Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-09-011169
Filing Date
2009-01-26
Accepted
2009-01-26 16:59:31
Documents
6
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-K d10ka.htm 10-K/A 519890
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 9515
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 9519
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906 dex321.htm EX-32.1 2793
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 906 dex322.htm EX-32.2 2797
6 CHARTER- AUDIT AND FINANCE COMMITTEE dex991.htm EX-99.1 33263
  Complete submission text file 0001193125-09-011169.txt   579271
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 6178618444
INDEVUS PHARMACEUTICALS INC (Filer) CIK: 0000854222 (see all company filings)

EIN.: 043047911 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 000-18728 | Film No.: 09545991
SIC: 2834 Pharmaceutical Preparations